子宫动脉栓塞术治疗子宫腺肌病所致 Asherman 综合征：发生率预测因素。
Asherman syndrome in adenomyosis treated with uterine artery embolization: incidence predictive factors.
机构信息
Department of Radiology, The First Affiliated Hospital, Anhui Medical University, 218 Jixi Street, Hefei, 230022, PA, People's Republic of China.
Department of Radiology, Women and Children Health Care Hospital Affiliated Hospital, Anhui Medical University, 15 Yimin Street, Hefei, 230022, PA, People's Republic of China.
出版信息
Radiol Med. 2020 May;125(5):437-443. doi: 10.1007/s11547-020-01136-8. Epub 2020 Feb 4.
PURPOSE
To investigate Asherman syndrome (AS) related to potential factors during uterine artery embolization (UAE) treatment of adenomyosis.
MATERIALS AND METHODS
This is a retrospective analysis of 195 women with adenomyosis who underwent UAE treatment from 2009 to 2016. All preoperative and intraoperative risk-related potential factors of AS were recorded. And AS events were carefully monitored during follow-up (range, 0-15 months). Potential risk-related factors of AS events were determined via univariate and multivariate logistic regression analyses.
RESULTS
The rate of AS events after UAE for adenomyosis was 12.82% (25/195). The univariate and multivariate analyses revealed the association of low vascularity with a significant risk for AS (P = 0.019).
CONCLUSION
Patients with low vascularity of adenomyosis at the time of UAE are more likely to have AS. And adenomyosis patients with low vascularity should be carefully selected to undergo UAE treatment.
目的
探讨子宫动脉栓塞术（UAE）治疗子宫腺肌病相关的 Asherman 综合征（AS）的潜在因素。
材料与方法
这是一项回顾性分析，纳入了 195 名于 2009 年至 2016 年期间接受 UAE 治疗的子宫腺肌病患者。记录了所有术前和术中与 AS 相关的潜在危险因素。并在随访期间（0-15 个月）仔细监测 AS 事件。通过单因素和多因素 logistic 回归分析确定 AS 事件的潜在风险相关因素。
结果
UAE 治疗子宫腺肌病后 AS 事件的发生率为 12.82%（25/195）。单因素和多因素分析显示，血管低灌注与 AS 的发生显著相关（P=0.019）。
结论
在 UAE 时血管低灌注的子宫腺肌病患者更易发生 AS。因此，血管低灌注的子宫腺肌病患者应谨慎选择接受 UAE 治疗。
Zotero 插件